Michael Quinn to Neoplasms
This is a "connection" page, showing publications Michael Quinn has written about Neoplasms.
Connection Strength
0.195
-
Cancer trends in the United States--a view from Europe. J Natl Cancer Inst. 2003 Sep 03; 95(17):1258-61.
Score: 0.081
-
Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol. 2003 Jul; 14(7):1148-52.
Score: 0.080
-
Cancer survival in England and Wales at the end of the 20th century. Br J Cancer. 2008 Sep 23; 99 Suppl 1:S2-10.
Score: 0.029
-
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy. Clin Cancer Res. 2005 Mar 01; 11(5):1890-8.
Score: 0.006